In this post, our Roundup lawyers will give you:
A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.
This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims.
The most serious lawsuits generally do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.
Our lawyers are investigating gambling addiction lawsuits involving DraftKings, FanDuel, BetMGM, Caesars, ESPN Bet, Bet365, Fanatics Sportsbook, Hard Rock Bet, and other online betting platforms. The core allegation is that these companies had the data to see compulsive gambling behavior and, instead of slowing users down, kept pushing them with bonus bets, deposit matches, push notifications, VIP hosts, profit boosts, same game parlays, microbets, and personalized offers.
If you or your child suffered serious harm from online sports betting addiction, the first question is not whether gambling was legal. The first question is whether the platform used design, data, and marketing to keep a vulnerable user betting when a responsible operator should have stepped in.
If you or someone you love has suffered severe financial and emotional harm because of addiction to online gambling or sports betting, contact our lawyers at 800-553-8082 or get a free, no-obligation online consultation.
Our lawyers are handling AFFF firefighting foam lawsuits around the country.
This page provides the most recent news and updates on the AFFF firefighting foam class action lawsuit and our prediction of the settlement amounts that plaintiffs with AFFF cancer lawsuits can expect to receive. You will not get more updated news on the AFFF litigation anywhere else.
Our lawyers are handling Taxotere eye injury lawsuits throughout the United States for women with permanently watery eyes from docetaxel.
Taxotere (docetaxel) is a widely used breast cancer chemotherapy drug. New evidence has emerged showing that Taxotere may be causing some users to suffer permanent vision loss or damage.
This has led to a wave of product liability Taxotere lawsuits by women who claim that Taxotere damaged their eyesight. The manufacturer of Taxotere, Sanofi, allegedly knew about the risk of vision damage but chose not to warn doctors or patients about this risk.
This page provides the latest news and updates on the 3M earplug lawsuits and the settlement in 2024. We continue to update this page to provide information to victims, but you can find even more quality information from other plaintiffs in the over 10,000 comments below. We are not handling new 3M earplug lawsuits. Continue reading
Dupixent lawsuits are now moving forward in federal court for patients who allege the drug caused, accelerated, or unmasked cutaneous T-cell lymphoma and related T-cell lymphomas. On June 4, 2026, the Judicial Panel on Multidistrict Litigation centralized the federal Dupixent cases in MDL No. 3180, In re: Dupixent (Dupilumab) Products Liability Litigation, in the District of New Jersey before Judge Zahid N. Quraishi.
Dupixent, also known as dupilumab, is a biologic medication used to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, COPD, bullous pemphigoid, allergic fungal rhinosinusitis, and other inflammatory conditions. For many patients, Dupixent has provided real relief where other treatments failed. But for some patients, the story has been very different.
The lawsuits allege that Regeneron and Sanofi failed to warn doctors and patients that cutaneous T-cell lymphoma, often called CTCL, can mimic eczema and that Dupixent may mask, accelerate, or delay diagnosis of an underlying lymphoma. Plaintiffs argue that patients with adult-onset, atypical, or treatment-resistant dermatitis should have been warned to rule out lymphoma before starting Dupixent and to stop and investigate if symptoms worsened or changed during treatment.
Our lawyers are actively reviewing hair relaxer cancer lawsuits across all 50 states. This page provides:
Our lawyers are handling Similac and Enfamil infant formula lawsuits for families whose premature babies suffered or died from necrotizing enterocolitis (NEC) after taking one of these formulas. Our law firm is reviewing NEC lawsuits in all 50 states.
Medical research links cow milk-based infant formulas such as Similac and Enfamil to a dangerous neonatal medical condition known as necrotizing enterocolitis. These newborn NEC formula lawsuits make many allegations. But at their core, they allege that the makers of these formulas knew of the risk of NEC and did nothing to warn families and give them a choice.
If your premature baby was diagnosed with NEC after being given Similac or Enfamil formula, you may be able to participate in a class action lawsuit against the formula companies and receive financial compensation for the harm that was done to your child.
Our lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit. Continue reading
Lawsuit Information Center